WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
UN food agency fears an escalation on the Lebanese
Want a healthy dog? Vets reveal the 10 extreme body conformations owners should AVOID including flat
Travellers share snaps of the worst behaved flight passengers
What REALLY happened the night of OJ Simpson and Kris Jenner allegedly hooked up in the hot tub
EDEN CONFIDENTIAL: US officials sink Prince Harry's 'vague' plan to trademark Sentebale charity
Podcast pick: The best audio show to listen to now
The hotel room on WHEELS! Self
Pay offer a 'significant loss' to frontline officers
An extremist group and ethnic militias committed atrocities in Mali, Human Rights Watch says
Six ways to use up surplus chocolate, meat and vegetables from Easter according to top chefs